John Wilkerson is a Washington correspondent for STAT who writes about the politics of health care. He is also the author of the twice-weekly D.C. Diagnosis newsletter. WASHINGTON — The Trump ...
Jan. 17 (UPI) --Drugs used to treat cancer, diabetes and other chronic conditions are among 15 picked for negotiations that could result in lower prices for patients, the Department of Health and ...
The IRA's second phase targets price negotiations for 15 medications, including semaglutide, to reduce costs for Medicare patients. Price negotiations, effective in 2027, cover drugs for diabetes, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results